As of 2025-08-25, the EV/EBITDA ratio of Fusion Pharmaceuticals Inc (FUSN) is -17.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FUSN's latest enterprise value is 1,854.94 mil USD. FUSN's TTM EBITDA according to its financial statements is -107.60 mil USD. Dividing these 2 quantities gives us the above FUSN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 9.2x | 7.7x |
| Forward P/E multiples | 17.6x - 26.4x | 22.0x |
| Fair Price | (22.52) - (11.95) | (19.04) |
| Upside | -204.5% - -155.4% | -188.4% |
| Date | EV/EBITDA |